Colette Shen, MD, PhD

University of North Carolina School of Medicine & Lineberger Comprehensive Cancer Center
Chapel Hill, North Carolina

Disclosures:

  • Employment: University of North Carolina-Chapel Hill:Assistant Professor:Employee
  • Compensation: Nanobiotix: Consultant, Travel Expenses-End Date: To present ;GT Medical Technologies: Consultant, Compensation Payment-End Date: To present ;AstraZeneca: Research Grants, Research Funding, Research Salary Support, Grant Research Funding-End Date: To present ;Johnson and Johnson: Consultant, Compensation Payment-End Date: to present
  • Ownership: none
  • Leadership: none

Presentations

Sep 29

245 - Phase I Dose Escalation/Dose Expansion Trial of NBTXR3/SBRT in Combination with Nivolumab or Pembrolizumab for the Treatment of anti-PD-1 Naïve or Resistant Patients with Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
03:30pm - 03:40pm PT